Mannkind (MNKD) Other Operating Expenses (2015 - 2026)
Mannkind (MNKD) posted quarterly Other Operating Expenses of $20.5 million for Q1 2026, up 2.48% year-over-year from $20.0 million in Q1 2025, and down 39.0% quarter-over-quarter from $33.6 million in Q4 2025.
Mannkind (MNKD) Other Operating Expenses (2015 - 2026) Analysis & Trends
Mannkind (MNKD) has reported Other Operating Expenses for 12 consecutive years, with $20.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses rose 2.48% year-over-year to $20.5 million; the TTM figure through Mar 2026 stood at $100.2 million (up 32.65% YoY), while the FY2025 annual figure was $99.7 million, up 37.12% from the prior year.
- Other Operating Expenses retreated to $20.5 million in Q1 2026 per MNKD's latest filing, from $33.6 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $33.6 million in Q4 2025 and bottomed at -$22.5 million in Q4 2022.
- Historically, Other Operating Expenses has averaged $18.3 million across 5 years, with a median of $20.5 million in 2026.
- On a YoY basis, Other Operating Expenses climbed as much as 476.43% in 2022 and fell as far as 140.69% in 2022.
- Mannkind's Other Operating Expenses stood at -$22.5 million in 2022, then advanced by 11.67% to -$19.9 million in 2023, then jumped by 176.2% to $15.2 million in 2024, then soared by 121.76% to $33.6 million in 2025, then slumped by 39.0% to $20.5 million in 2026.
- Business Quant data shows MNKD's Other Operating Expenses at $20.5 million in Q1 2026, $33.6 million in Q4 2025, and $20.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Mannkind | 1.19 Bn | 1.08 Bn | 94.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.42 Mn |
| Mar 31, 2026 | 20.52 Mn |
| Dec 31, 2025 | 33.64 Mn |
| Sep 30, 2025 | 20.08 Mn |
| Jun 30, 2025 | 25.93 Mn |
| Mar 31, 2025 | 20.03 Mn |
| Dec 31, 2024 | 15.17 Mn |
| Sep 30, 2024 | 20.48 Mn |
| Jun 30, 2024 | 19.85 Mn |
| Mar 31, 2024 | 17.20 Mn |
| Dec 31, 2023 | -19.91 Mn |
| Sep 30, 2023 | 25.63 Mn |
| Jun 30, 2023 | 28.49 Mn |
| Mar 31, 2023 | 30.48 Mn |
| Dec 31, 2022 | -22.54 Mn |
| Sep 30, 2022 | 29.20 Mn |
| Jun 30, 2022 | 24.28 Mn |
| Mar 31, 2022 | 21.74 Mn |
| Dec 31, 2021 | 55.40 Mn |
| Sep 30, 2021 | 7.93 Mn |